Catalent Inc. (CTLT) |
|
78.01 -1.14 (-1.44%)
|
07-10 16:00 |
|
Open: |
78.76 |
Pre. Close: |
79.15 |
|
High:
|
78.985 |
Low:
|
77.25 |
|
Volume:
|
1,494,973 |
Market Cap:
|
12,779M |
|
|
|
|
Catalent, Inc. provides delivery technologies and development solutions for drugs, biologics, and consumer and animal health products worldwide. It operates through four segments: Softgel Technologies, Biologics and Specialty Drug Delivery, Oral Drug Delivery, and Clinical Supply Services. The Softgel Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products, such as prescription drugs, over-the-counter medications, dietary supplements, unit-dose cosmetics, and animal health medicinal preparations. The Biologics and Specialty Drug Delivery segment engages in the drug substance development and manufacturing; drug product clinical and commercial manufacturing; and integrated clinical and commercial supply solutions for protein and gene therapy biologics and specialty small molecules through injection, inhalation, and ophthalmic routes. |
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
79.053 - 79.453 |
79.453 - 79.709 |
|
Low:
|
76.294 - 76.826 |
76.826 - 77.165 |
|
Close:
|
77.236 - 78.04 |
78.04 - 78.554 |
|
Technical analysis |
as of: 2020-07-10 4:26:41 PM |
|
Overall:
|
  |
| Stoxline posted a NEUTRAL today, downgraded from higher rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell. |
| Target: |
Six months: 92.54 One year: 108.09 |
| Support: |
Support1: 72.27 Support2: 67.97 |
| Resistance: |
Resistance1: 79.23 Resistance2: 92.54 |
| Pivot: |
73.54  |
| Moving Average: |
MA(5): 76.13 MA(20): 72.83
MA(100): 62.78 MA(250): 57.37 |
| MACD: |
MACD(12,26): 1.22 Signal(9): 0.60 |
| Stochastic oscillator: |
%K(14,3): 95.21 %D(3): 93.63 |
| RSI: |
RSI(14): 63.64 |
| 52-week: |
High: 80.52 Low: 31.04 Change(%): 44.5 |
| Average Vol(K): |
3-Month: 155955 10-Days: 124138 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.CTLT has closed below upper band by 3.2%. Bollinger Bands are 27.4% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices. |
|
|
Headline News |
Fri, 10 Jul 2020
Why Do Investors Care About Catalent, Inc. (CTLT) - The News Heater
Fri, 10 Jul 2020
Catalent: A New Buy in Vaccine Development - Moneyshow.com
Thu, 09 Jul 2020
Is Catalent's (NYSE:CTLT) Share Price Gain Of 155% Well Earned? - Yahoo Finance
Tue, 07 Jul 2020
How Much Are Catalent, Inc. (NYSE:CTLT) Insiders Spending On Buying Shares? - Simply Wall St
Tue, 07 Jul 2020
Catalent, Inc. (CTLT) Bears Seem To Be Pulling The Price Back - Invest Million
Wed, 01 Jul 2020
Scott Gunther Sells 2,824 Shares of Catalent Inc (NYSE:CTLT) Stock - MarketBeat
|
Financial Analysis |
| Growth |
 |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
|
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
 |
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
 |
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Click here to get more fundamental analysis.
|
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: New York Stock Exchange |
| Sector: Healthcare |
| Industry: Drug ManufacturersSpecialty & Generic |
| Shares Out. (M) |
164 |
| Shares Float (M) |
154 |
|
% Held by Insiders
|
0.67 |
|
% Held by Institutions
|
99.09 |
|
Shares Short (K)
|
3,000 |
|
Shares Short P. Month (K)
|
2,710 |
Stock Financials |
|
EPS
|
0.690 |
|
EPS Est This Year
|
1.630 |
|
EPS Est Next Year
|
1.820 |
|
Book Value (p.s.)
|
14.130 |
|
Profit Margin
|
4.79 |
|
Operating Margin
|
12.72 |
|
Return on Assets (ttm)
|
4.0 |
|
Return on Equity (ttm)
|
6.2 |
|
Qtrly Rev. Growth
|
23.2 |
|
Gross Profit (p.s.)
|
4.915 |
|
Sales Per Share
|
17.520 |
|
EBITDA (p.s.)
|
3.707 |
|
Qtrly Earnings Growth
|
-34.10 |
|
Operating Cash Flow (M)
|
356 |
|
Levered Free Cash Flow (M)
|
9 |
Stock Valuations |
|
PE Ratio
|
113.04 |
|
PEG Ratio
|
|
|
Price to Book value
|
5.52 |
|
Price to Sales
|
4.45 |
|
Price to Cash Flow
|
35.94 |
Stock Dividends |
|
Dividend
|
|
|
Forward Dividend
|
|
|
Dividend Yield
|
|
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
7 Binary Options
|
|
Your Ad Here
|
|
